-
1
-
-
33645347973
-
Cannabinoids in medicine: A review of their therapeutic potential
-
1:CAS:528:DC%2BD28XjtFOlsrg%3D 16540272
-
Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006;105:1-25.
-
(2006)
J Ethnopharmacol
, vol.105
, pp. 1-25
-
-
Ben Amar, M.1
-
2
-
-
1842611887
-
The endocannabinoid system: A general view and latest additions
-
14744801 1574255
-
Petrocellis LD, Cascio MG, Marzo VD. The endocannabinoid system: a general view and latest additions. Br J Pharmacol. 2004;141:765-74.
-
(2004)
Br J Pharmacol
, vol.141
, pp. 765-774
-
-
Petrocellis, L.D.1
Cascio, M.G.2
Marzo, V.D.3
-
3
-
-
27644567089
-
Cannabinoids and the digestive tract
-
ISSN: 0171-2004
-
Izzo AA, Coutts AA. Cannabinoids and the digestive tract. Handb Exp Pharmacol. 2005:573-598. ISSN: 0171-2004.
-
(2005)
Handb Exp Pharmacol
, pp. 573-598
-
-
Izzo, A.A.1
Coutts, A.A.2
-
4
-
-
84857931127
-
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
-
1:CAS:528:DC%2BC38XmsFGntLY%3D 22414698 3668621
-
Schicho R, Storr M. Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice. Pharmacology. 2012;89:149-55.
-
(2012)
Pharmacology
, vol.89
, pp. 149-155
-
-
Schicho, R.1
Storr, M.2
-
5
-
-
80051664599
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
1:CAS:528:DC%2BC3MXhtVagtbjI 21238581 3085542
-
Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med. 2011;51:1054-61.
-
(2011)
Free Radic Biol Med
, vol.51
, pp. 1054-1061
-
-
Booz, G.W.1
-
6
-
-
35649015179
-
The orphan receptor GPR55 is a novel cannabinoid receptor
-
1:CAS:528:DC%2BD2sXhtlCrsbnI 17876302 2095107
-
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152:1092-101.
-
(2007)
Br J Pharmacol
, vol.152
, pp. 1092-1101
-
-
Ryberg, E.1
Larsson, N.2
Sjogren, S.3
Hjorth, S.4
Hermansson, N.O.5
Leonova, J.6
Elebring, T.7
Nilsson, K.8
Drmota, T.9
Greasley, P.J.10
-
7
-
-
0038845604
-
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
-
1:CAS:528:DyaK1MXns1yjs7w%3D 10570211 24203
-
Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A. 1999;96:14136-41.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 14136-14141
-
-
Jarai, Z.1
Wagner, J.A.2
Varga, K.3
Lake, K.D.4
Compton, D.R.5
Martin, B.R.6
Zimmer, A.M.7
Bonner, T.I.8
Buckley, N.E.9
Mezey, E.10
-
8
-
-
70449522049
-
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
-
1:CAS:528:DC%2BD1MXhtlKit73L
-
Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V, Izzo AA. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med (Berl). 2009;87:1111-21.
-
(2009)
J Mol Med (Berl)
, vol.87
, pp. 1111-1121
-
-
Borrelli, F.1
Aviello, G.2
Romano, B.3
Orlando, P.4
Capasso, R.5
Maiello, F.6
Guadagno, F.7
Petrosino, S.8
Capasso, F.9
Di Marzo, V.10
Izzo, A.A.11
-
9
-
-
79960275004
-
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
-
21744421
-
Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, et al. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis. 2011;17:1651-64.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1651-1664
-
-
Schicho, R.1
Bashashati, M.2
Bawa, M.3
McHugh, D.4
Saur, D.5
Hu, H.M.6
Zimmer, A.7
Lutz, B.8
Mackie, K.9
Bradshaw, H.B.10
-
10
-
-
77952731052
-
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
-
20346144 2865488
-
McHugh D, Hu S, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw H. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci. 2010;11:44.
-
(2010)
BMC Neurosci
, vol.11
, pp. 44
-
-
McHugh, D.1
Hu, S.2
Rimmerman, N.3
Juknat, A.4
Vogel, Z.5
Walker, J.M.6
Bradshaw, H.7
-
11
-
-
35648959293
-
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
-
1:CAS:528:DC%2BD2sXht1ejt7vE 17704827 2190033
-
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, et al. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol. 2007;152:825-31.
-
(2007)
Br J Pharmacol
, vol.152
, pp. 825-831
-
-
Johns, D.G.1
Behm, D.J.2
Walker, D.J.3
Ao, Z.4
Shapland, E.M.5
Daniels, D.A.6
Riddick, M.7
Dowell, S.8
Staton, P.C.9
Green, P.10
-
12
-
-
84939864671
-
Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles
-
26098470
-
Su EN, Kelly ME, Cringle SJ, Yu DY. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles. Invest Ophthalmol Vis Sci. 2015;56:4029-37.
-
(2015)
Invest Ophthalmol Vis Sci
, vol.56
, pp. 4029-4037
-
-
Su, E.N.1
Kelly, M.E.2
Cringle, S.J.3
Yu, D.Y.4
-
13
-
-
62149143788
-
2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells
-
18837048
-
Kreutz S, Koch M, Bottger C, Ghadban C, Korf HW, Dehghani F. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells. Glia. 2009;57:286-94.
-
(2009)
Glia
, vol.57
, pp. 286-294
-
-
Kreutz, S.1
Koch, M.2
Bottger, C.3
Ghadban, C.4
Korf, H.W.5
Dehghani, F.6
-
14
-
-
34547503869
-
Mucosal Healing in Inflammatory Bowel Disease: Results from a Norwegian Population-Based Cohort
-
17681162
-
Frøslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort. Gastroenterology. 2007;133:412-22.
-
(2007)
Gastroenterology
, vol.133
, pp. 412-422
-
-
Frøslie, K.F.1
Jahnsen, J.2
Moum, B.A.3
Vatn, M.H.4
-
15
-
-
84871028685
-
Mucosal healing in ulcerative colitis: Pathophysiology and pharmacology
-
1:CAS:528:DC%2BC3sXpt1Ons7c%3D 23461134
-
Seidelin JB, Coskun M, Nielsen OH. Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. Adv Clin Chem. 2013;59:101-23.
-
(2013)
Adv Clin Chem
, vol.59
, pp. 101-123
-
-
Seidelin, J.B.1
Coskun, M.2
Nielsen, O.H.3
-
16
-
-
58449083070
-
Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide
-
1:CAS:528:DC%2BD1MXhslyrtLs%3D
-
Engel M, Kellerman C, Rau T, Burnat G, Hahn E, Konturek P. Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. Acta Physiol Pol. 2008;59:673.
-
(2008)
Acta Physiol Pol
, vol.59
, pp. 673
-
-
Engel, M.1
Kellerman, C.2
Rau, T.3
Burnat, G.4
Hahn, E.5
Konturek, P.6
-
17
-
-
72549108949
-
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
-
19408320
-
Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis. 2009;15:1678-85.
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 1678-1685
-
-
Storr, M.A.1
Keenan, C.M.2
Zhang, H.3
Patel, K.D.4
Makriyannis, A.5
Sharkey, K.A.6
-
18
-
-
0021742157
-
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models
-
1:CAS:528:DyaL2MXktVym 6092199
-
Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984;87:1344-50.
-
(1984)
Gastroenterology
, vol.87
, pp. 1344-1350
-
-
Krawisz, J.E.1
Sharon, P.2
Stenson, W.F.3
-
19
-
-
11144255122
-
Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice
-
1:STN:280:DC%2BD2cnis1ersg%3D%3D 15601431
-
Kimball ES, Wallace NH, Schneider CR, D'Andrea MR, Hornby PJ. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil. 2004;16:811-8.
-
(2004)
Neurogastroenterol Motil
, vol.16
, pp. 811-818
-
-
Kimball, E.S.1
Wallace, N.H.2
Schneider, C.R.3
D'Andrea, M.R.4
Hornby, P.J.5
-
20
-
-
0035905495
-
Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: A role for endothelium-associated eotaxin-3
-
1:CAS:528:DC%2BD38Xpt1Wn 11748272 2193583
-
Cuvelier SL, Patel KD. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med. 2001;194:1699-709.
-
(2001)
J Exp Med
, vol.194
, pp. 1699-1709
-
-
Cuvelier, S.L.1
Patel, K.D.2
-
21
-
-
0022337475
-
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro
-
1:CAS:528:DyaL28Xos1artg%3D%3D 4077977 424346
-
Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest. 1985;76:2235-46.
-
(1985)
J Clin Invest
, vol.76
, pp. 2235-2246
-
-
Zimmerman, G.A.1
McIntyre, T.M.2
Prescott, S.M.3
-
22
-
-
0030823317
-
Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells
-
1:CAS:528:DyaK2sXmslOkurY%3D 9327754
-
Aepfelbacher M, Essler M, Huber E, Sugai M, Weber PC. Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:1623-9.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 1623-1629
-
-
Aepfelbacher, M.1
Essler, M.2
Huber, E.3
Sugai, M.4
Weber, P.C.5
-
23
-
-
0242584643
-
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor
-
1:CAS:528:DC%2BD3sXitFyrtr4%3D 12606780
-
Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol. 2003;63:699-705.
-
(2003)
Mol Pharmacol
, vol.63
, pp. 699-705
-
-
Offertaler, L.1
Mo, F.M.2
Batkai, S.3
Liu, J.4
Begg, M.5
Razdan, R.K.6
Martin, B.R.7
Bukoski, R.D.8
Kunos, G.9
-
24
-
-
84858630089
-
Multiple Roles for Neutrophils in Atherosclerosis
-
1:CAS:528:DC%2BC38XjslKnt7k%3D 22427325
-
Soehnlein O. Multiple Roles for Neutrophils in Atherosclerosis. Circ Res. 2012;110:875-88.
-
(2012)
Circ Res
, vol.110
, pp. 875-888
-
-
Soehnlein, O.1
-
25
-
-
0026785837
-
Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis
-
1:STN:280:DyaK3s%2FjsFWrtQ%3D%3D 1329495
-
Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol. 1992;87:1447-52.
-
(1992)
Am J Gastroenterol
, vol.87
, pp. 1447-1452
-
-
Izzo, R.S.1
Witkon, K.2
Chen, A.I.3
Hadjiyane, C.4
Weinstein, M.I.5
Pellecchia, C.6
-
26
-
-
0036282421
-
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis
-
1:CAS:528:DC%2BD38XislOqsLg%3D 11889070 1773167
-
Carlson M, Raab Y, Seveus L, Xu S, Hallgren R, Venge P. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut. 2002;50:501-6.
-
(2002)
Gut
, vol.50
, pp. 501-506
-
-
Carlson, M.1
Raab, Y.2
Seveus, L.3
Xu, S.4
Hallgren, R.5
Venge, P.6
-
27
-
-
0038576426
-
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
-
1:STN:280:DC%2BD3s3hvFSksA%3D%3D 12740341 1773692
-
Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003;52:847-53.
-
(2003)
Gut
, vol.52
, pp. 847-853
-
-
Foell, D.1
Kucharzik, T.2
Kraft, M.3
Vogl, T.4
Sorg, C.5
Domschke, W.6
Roth, J.7
-
28
-
-
51449114896
-
Accumulation, activation, and survival of neutrophils in ulcerative colitis: Regulation by locally produced factors in the colon and impact of steroid treatment
-
18594843
-
Lampinen M, Sangfelt P, Taha Y, Carlson M. Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment. Int J Colorectal Dis. 2008;23:939-46.
-
(2008)
Int J Colorectal Dis
, vol.23
, pp. 939-946
-
-
Lampinen, M.1
Sangfelt, P.2
Taha, Y.3
Carlson, M.4
-
29
-
-
34548230927
-
Getting to the site of inflammation: The leukocyte adhesion cascade updated
-
1:CAS:528:DC%2BD2sXpsV2qtb0%3D 17717539
-
Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-89.
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 678-689
-
-
Ley, K.1
Laudanna, C.2
Cybulsky, M.I.3
Nourshargh, S.4
-
30
-
-
33947716172
-
Endothelial Function and Dysfunction: Testing and Clinical Relevance
-
17353456
-
Deanfield JE, Halcox JP, Rabelink TJ. Endothelial Function and Dysfunction: Testing and Clinical Relevance. Circulation. 2007;115:1285-95.
-
(2007)
Circulation
, vol.115
, pp. 1285-1295
-
-
Deanfield, J.E.1
Halcox, J.P.2
Rabelink, T.J.3
-
31
-
-
40049097099
-
Epithelial restitution and wound healing in inflammatory bowel disease
-
1:CAS:528:DC%2BD1cXjvFKkt70%3D 18200658 2679124
-
Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol. 2008;14:348-53.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 348-353
-
-
Sturm, A.1
Dignass, A.U.2
-
32
-
-
84871755412
-
Inflammatory bowel disease: An impaired barrier disease
-
23160753
-
Jager S, Stange EF, Wehkamp J. Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg. 2013;398:1-12.
-
(2013)
Langenbecks Arch Surg
, vol.398
, pp. 1-12
-
-
Jager, S.1
Stange, E.F.2
Wehkamp, J.3
-
33
-
-
23244457833
-
Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing
-
16083701
-
Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M, Ward S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology. 2005;129:437-53.
-
(2005)
Gastroenterology
, vol.129
, pp. 437-453
-
-
Wright, K.1
Rooney, N.2
Feeney, M.3
Tate, J.4
Robertson, D.5
Welham, M.6
Ward, S.7
-
34
-
-
83755219473
-
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
-
22001864 e42; quiz e30
-
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54. e42; quiz e30.
-
(2012)
Gastroenterology
, vol.142
, pp. 46-54
-
-
Molodecky, N.A.1
Soon, I.S.2
Rabi, D.M.3
Ghali, W.A.4
Ferris, M.5
Chernoff, G.6
Benchimol, E.I.7
Panaccione, R.8
Ghosh, S.9
Barkema, H.W.10
Kaplan, G.G.11
-
35
-
-
77649275461
-
Cannabinoids and the gut: New developments and emerging concepts
-
1:CAS:528:DC%2BC3cXjt1Kgs7g%3D 20117132
-
Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010;126:21-38.
-
(2010)
Pharmacol Ther
, vol.126
, pp. 21-38
-
-
Izzo, A.A.1
Sharkey, K.A.2
-
36
-
-
67449135862
-
Cannabinoids in intestinal inflammation and cancer
-
1:CAS:528:DC%2BD1MXnvVWmsr0%3D 19442536
-
Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res. 2009;60:117-25.
-
(2009)
Pharmacol Res
, vol.60
, pp. 117-125
-
-
Izzo, A.A.1
Camilleri, M.2
-
37
-
-
54749112350
-
Modulation of the endocannabinoid system in cardiovascular disease: Therapeutic potential and limitations
-
1:CAS:528:DC%2BD1cXhtV2jsrrL 18779440 2568884
-
Pacher P, Mukhopadhyay P, Mohanraj R, Godlewski G, Batkai S, Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52:601-7.
-
(2008)
Hypertension
, vol.52
, pp. 601-607
-
-
Pacher, P.1
Mukhopadhyay, P.2
Mohanraj, R.3
Godlewski, G.4
Batkai, S.5
Kunos, G.6
-
39
-
-
33645832524
-
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
-
16403786
-
D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J. 2006;20:568-70.
-
(2006)
FASEB J
, vol.20
, pp. 568-570
-
-
D'Argenio, G.1
Valenti, M.2
Scaglione, G.3
Cosenza, V.4
Sorrentini, I.5
Di Marzo, V.6
-
40
-
-
4143108422
-
Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors
-
1:CAS:528:DyaK2sXlvVGls7c%3D 191-197
-
Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci. 1997;61:PL 191-197.
-
(1997)
Life Sci
, vol.61
, pp. PL
-
-
Gatley, S.J.1
Lan, R.2
Pyatt, B.3
Gifford, A.N.4
Volkow, N.D.5
Makriyannis, A.6
-
41
-
-
77952660029
-
GPR55 ligands promote receptor coupling to multiple signalling pathways
-
1:CAS:528:DC%2BC3cXpslyru7s%3D 20136841 2931561
-
Henstridge CM, Balenga NA, Schroder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, et al. GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol. 2010;160:604-14.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 604-614
-
-
Henstridge, C.M.1
Balenga, N.A.2
Schroder, R.3
Kargl, J.K.4
Platzer, W.5
Martini, L.6
Arthur, S.7
Penman, J.8
Whistler, J.L.9
Kostenis, E.10
-
42
-
-
2942733214
-
Role of Endothelial Dysfunction in Atherosclerosis
-
Davignon J, Ganz P. Role of Endothelial Dysfunction in Atherosclerosis. Circulation. 2004;109:III-27-32.
-
(2004)
Circulation
, vol.109
, pp. III27-III32
-
-
Davignon, J.1
Ganz, P.2
-
43
-
-
33748988205
-
Neutrophil transepithelial migration and epithelial barrier function in IBD: Potential targets for inhibiting neutrophil trafficking
-
1:CAS:528:DC%2BD28XhtVOjurbP 17057207
-
Chin AC, Parkos CA. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci. 2006;1072:276-87.
-
(2006)
Ann N y Acad Sci
, vol.1072
, pp. 276-287
-
-
Chin, A.C.1
Parkos, C.A.2
-
44
-
-
0035185891
-
Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins
-
1:CAS:528:DC%2BD38Xhslarsg%3D%3D 11733350 1850599
-
Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159:2001-9.
-
(2001)
Am J Pathol
, vol.159
, pp. 2001-2009
-
-
Kucharzik, T.1
Walsh, S.V.2
Chen, J.3
Parkos, C.A.4
Nusrat, A.5
-
45
-
-
0037043658
-
Inflammatory bowel disease
-
1:CAS:528:DC%2BD38XlvFKrt7s%3D 12167685
-
Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-29.
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
46
-
-
0030067724
-
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
-
1:STN:280:DyaK283ks1elsg%3D%3D 8801200 1383026
-
Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 1996;38:216-22.
-
(1996)
Gut
, vol.38
, pp. 216-222
-
-
Daig, R.1
Andus, T.2
Aschenbrenner, E.3
Falk, W.4
Scholmerich, J.5
Gross, V.6
-
47
-
-
0001824595
-
Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells
-
1:STN:280:DC%2BC3s3mt1Wjtw%3D%3D 23283312
-
Izutani R, Loh EY, Reinecker HC, Ohno Y, Fusunyan RD, Lichtenstein GR, Rombeau JL, Macdermott RP. Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflamm Bowel Dis. 1995;1:37-47.
-
(1995)
Inflamm Bowel Dis
, vol.1
, pp. 37-47
-
-
Izutani, R.1
Loh, E.Y.2
Reinecker, H.C.3
Ohno, Y.4
Fusunyan, R.D.5
Lichtenstein, G.R.6
Rombeau, J.L.7
Macdermott, R.P.8
-
48
-
-
27144468308
-
Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention
-
1:CAS:528:DC%2BD2MXhtFKmsr7N 15990353
-
Johnson Z, Proudfoot AE, Handel TM. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 2005;16:625-36.
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, pp. 625-636
-
-
Johnson, Z.1
Proudfoot, A.E.2
Handel, T.M.3
-
49
-
-
19944428045
-
Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration
-
1:CAS:528:DC%2BD2cXhtFGmurnF 15611287 2212000
-
Shaw SK, Ma S, Kim MB, Rao RM, Hartman CU, Froio RM, Yang L, Jones T, Liu Y, Nusrat A, et al. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med. 2004;200:1571-80.
-
(2004)
J Exp Med
, vol.200
, pp. 1571-1580
-
-
Shaw, S.K.1
Ma, S.2
Kim, M.B.3
Rao, R.M.4
Hartman, C.U.5
Froio, R.M.6
Yang, L.7
Jones, T.8
Liu, Y.9
Nusrat, A.10
-
50
-
-
38549130466
-
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: Evidence for a site distinct from CB1 and CB2
-
1:CAS:528:DC%2BD1cXht1ymsbc%3D 17965195
-
McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol. 2008;73:441-50.
-
(2008)
Mol Pharmacol
, vol.73
, pp. 441-450
-
-
McHugh, D.1
Tanner, C.2
Mechoulam, R.3
Pertwee, R.G.4
Ross, R.A.5
|